SEC
ACOR

Seven Eight Capital’s Acorda Therapeutics ACOR Stock Holding History

Seven Eight Capital’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3
Closed -$10K – 698
2015
Q1 		$10K Buy
+3
New +$13.7K 0.02% 399

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Seven Eight Capital's ACOR Position: Q2 2015 in Review

Seven Eight Capital sold out of Acorda Therapeutics (ACOR) in Q2 2015, closing a stake of 3 shares — an estimated $10K sold.

Seven Eight Capital first reported a position in ACOR in Q1 2015 and held it in 1 quarter. The position peaked at $10K in Q1 2015. 170 funds tracked by Wall St. Rank hold ACOR as of Q2 2015.

  • Seven Eight Capital reported no remaining Acorda Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Seven Eight Capital sold 3 Acorda Therapeutics shares in Q2 2015, an estimated $10K.
  • Seven Eight Capital first reported a position in Acorda Therapeutics in Q1 2015 and held it in 1 quarter.
  • Seven Eight Capital's Acorda Therapeutics position peaked at $10K in Q1 2015.
  • 170 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2015.

Based on Seven Eight Capital's 13F filing for Q2 2015, filed 14 Aug 2015.